Member Info for rivaldo

Numis raise forecasts, and target price to 455p.... http ://www.proactiveinvestors.co.uk/companies/news/191066/numis-ups-target-price-for-discoverie-after-raising-estimates-following-recent-dutch-acquisition-191066.html "Numis ups target price for DiscoverIE after raising estimates following recent Dutch acquisition 11:13 02 Feb 2018 The City broker�s analysts upgraded their full-year 2019-2020 earnings per share forecasts for DiscoverIE by 7-8%, leading them to increase their share price target to 455p Numis Securities has upped its target price for DiscoverIE Group PLC (LON:DSCV) after raising estimates following the recent news of the �23.7mln acquisition of Santon, a designer and manufacturer of patented direct current switches. In a note to clients, Numis�s analysts said: �We view this as an attractive acquisition, significantly enhancing the Group's exposure to the structurally growing renewables (particularly solar) market, as well as boosting geographic diversification (particularly Asia).� The City broker�s analysts upgraded their full-year 2019-2020 earnings per share forecasts for the customised electronics supplier � formerly known as Acal PLC - by 7-8%, leading them to increase their share price target to 455p. With the shares currently trading at 395p each, the Numis analysts reiterated an �add� recommendation on DiscoverIE. They concluded: �The shares now trade on a FY19E PE of 14.8x and EV/EBITA of 10.9x, which we view as undemanding given the cyclical and structural tailwinds to which DiscoverIE is exposed.�

New video interview with the CEO - 2018 will be a "good year", happy to stay on AIM, lots of cash in the bank etc: Http ://www.proactiveinvestors.co.uk/companies/stocktube/8692/keywords-studios-in-a-good-position-with-a-strong-pipeline-of-acquisitions-8692.html Andrew sounds as confident as ever :o))

Decent �20,000 buy at the full 270p offer price just now.

Good to see the QSI acquisition completed today - and Finncap have raised their price target to 34p. Finncap have also raised their forecast for next year slightly to 2.3p EPS. They still go for 2p EPS for the year finishing in April, which seems bizarre considering (1) SDI made 1.22p EPS in H1 alone, (2) there haven't been any material share issues and (3) SDI have a general seasonal bias towards H2.

From Finncap's 16 page note last week, it's worth noting the spectacular major shareholder list for such a small company, accounting for 60% of the shares in issue: Business Growth Fund 12.0% Octopus Investments 8.6% Herald Inv Mgt 8.5% Miton Group 7.7% Hargreave Lansdown 4.3% Hargreave Hale 4.1% TD Direct 4.0% Dana Investments 3.9% Charles Stanley 3.7% Barclays Stockbrokers 3.2%

Worth noting that RNWH went ex-div today for the 6p final dividend, so today's move isn't quite as drastic as at first look!

I was at a presentation yesterday by Amati Global Investors talking about their funds/VCTs etc. They specifically mentioned that ACSO was still a Buy as (and I quote): "it can continue to produce exceptional levels of EPS growth for many, many years to come".

N+1 Singer have reiterated their forecasts for this year of: 13.2p EPS 3.7p dividend �11.3m closing cash, which will be reviewed - and presumably increased significantly - following March's results. Looks like some traders were stuffed by the MMs this morning. Bouncing nicely now, and hopefully a much bigger bounce to come given the cheap fundamentals, transforming profile of the company, strong Balance Sheet and concentration on margins and high quality business.

It's ironic that the share price should fall just when MPs finally voted yesterday to move out of Parliament to allow repairs to begin. When this happens it will cost �billions and should provide huge work for RNWH given their lead role at the building. Meanwhile, RNWH will continue to work on maintaining and improving the current buildings and potentially preparing the new venue too: Https://edition.cnn.com/2018/01/31/europe/uk-houses-of-parliament-renovation-vote-intl/index.html RNWH are now looking remarkably cheap imho on a current year P/E of only 11 and with earnings-enhancing acquisitions likely.

Berenberg today raise their target price to 2040p: Http://www.morningstar.co.uk/uk/news/AN_1517477720763685400/broker-ratings-summary-morgan-stanley-neutral-on-rolls-royce-and-bae.aspx

Not bad for a �35m m/cap company...... "The Board is pleased to report that the expected outcome for the year is in line with current market expectations, which are an underlying profit before taxation of circa �6.5m and revenues in the region of �310m." And the cash pile is up to almost �12m - 33% of the m/cap. Order books are up year on year, despite CTO only taking on high quality, good margin work. Which is why they have immaterial exposure to the likes of Carillion. Which is summed up by: "We will continue to target projects for margin growth from our core M&E markets as well as our other developing revenue streams, particularly in the areas of technology and digital integration."

Nice sizeable acquisition today, earnings-enhancing for the coming year. And in high-margin D&M, plus in the growing renewables and transportation sectors. Good to see the founder staying with the business too: Http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/DSCV/13517244.html "Nick Jefferies, Group Chief Executive of discoverIE plc, said: "The acquisition of Santon continues our strategy of growing discoverIE into a highly differentiated, international electronics design and manufacturing group. With a long-established track record of producing high quality DC switches, Santon builds our position in niche components for solar power, a market that is set to grow significantly, and will create new opportunities in our other target markets such as transportation and medical."

I love to see the phrase "comfortably ahead of consensus market expectations" :o)) Plus much optimism for the future. And almost �50m of cash and facilities for more acquisitions too, so loads of headroom for more news flow to come. KWS appear to have developed the perfect strategy for the times, given this from today's RNS: "As games are becoming bigger and are higher definition, game developers are increasingly relying upon co-development arrangements with companies like Keywords to provide them with broader capability to develop both initial games and ongoing content and features post-launch."

Finncap say Buy with a 586p price target (40% upside). They note that "Renew could see some benefit from Carillion's demise with rail maintenance a key target", via (1) increased market share on the national network or (2) with London Underground through the Giffen acquisition. This is all "essential maintenance work". Funnily enough, Finncap quote "Renew's strong balance sheet" and strong reputation as being attractive to ex-Carillion clients. They believe their is "significant upside", due to: - "ROCE significantly ahead of the peer group" - "strong balance sheet" - "prospect of reinvesting cash flow into enhancing acquisitions"

Excellent new article in the Cambridge News. I particularly like the potential for ProReveal going forward: Https://www.cambridge-news.co.uk/business/cambridge-technology-firm-doubled-pre-14219564 "whilst the interim statement reported that 11 systems had now been adopted to date by teaching Hospitals across the UK, Creedon does point out to me that this has now increased since October to 15 and the company does expect further to come through as the DOH is now following up with an additioanal letter to Hospitals regarding guidance which states that all acute care settings should be testing for protein contamination by July of this year. Although sales of ProReveal have arguably been slow, the product, which is a proven piece of armoury in the fight against infection is now at long last seemingly attracting interest and signs of wider adoption where Creedon sounds a more positive tone on prospects going forward. �We are really concentrating on the UK market for now and have ironed out some minor issues with the consumables that has resulted in our manufacturing these in a more professional environment�. Such consumables, or recurring revenue as referred to, could prove to be a very handy addition to the sales of ProReveal where with 200 sterile service departments to target and potential for sales of �2m, annual ongoing income would come in at north of �0.5m. It isn't however confined to the UK though as the US and other territories could also feature in driving growth moving forward as an increasingly wider industry awareness gains traction."

Nice, solid trading update in line with expectations. Higher margin Engineering Services order books are up even if the overall order book is slightly down. I'd expect another acquisition soon since it's been a while since the last one: Http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/RNWH/13515355.html

What an excellent Q3 trading update - trading continued "strongly", sales up 13%, orders up 4%, margins improving..... Http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/DSCV/13515338.html Plus a strong hint of action to come: "In line with its strategy to grow its higher margin Design & Manufacturing division, the Group has several acquisition opportunities in the pipeline and has debt funding resources available."

Tipped as follows by the IC's Simon Thompson - hopefully more buying to come tomorrow: "Gama in the ascent Shares in Aim-traded Gama Aviation (GMAA:260p), an operator of privately owned jet aircraft, have reacted positively to a pre-close trading update ahead of results on Monday, 19 March 2018. I expect the share price to continue to make headway towards the 325p target price I set out at the time of the interims ('Riding earnings momentum', 6 September 2017). Analyst John Cummins at broking house WH Ireland expects revenues to have climbed by over a third to $586m in 2017, buoyed by significant growth in Gama�s US air division following the Landmark fleet joint venture with BBA Aviation (BBA), and in its US ground handling business, too. As expected Gama�s European air division has produced a far better margin improvement on the back of cost savings. As a result, pre-tax profits are forecast to rise by 28 per cent to $17.5m and deliver EPS of 32.9�. The strong operational progress is set to continue in the new financial year especially as the US economy remains buoyant, suggesting that Mr Cummins� EPS estimate of 36� is well supported. On this basis, Gama�s shares are rated on 10 times earnings estimates. One reason for the modest rating is that Gama is involved in legal proceedings relating to its legacy Hangar 8 business brought by its former chief executive Dustin Dryden who resigned in September 2015. In a separate case, the company is trying to recover a long standing trade receivable on which it holds adequate security. The board expect the net effect of these proceedings to lead to a net cash inflow to the company. I am unconcerned. More importantly, with net debt reduced by almost a third to $13m year-on-year, and the trading outlook upbeat, I would expect a hike on last year�s dividend of 2.6p a share and see potential for further earnings-accretive bolt-on acquisitions. Buy."

Great move up today. Encouraging to see today's rise on such unusually heavy volumes, with around �500,000 traded today. Plus the late 150,000 buy at 34.5p augurs well.

The IC say Buy in a quick snippet as follows: "Shares in Inspired Energy (INSE) are up 2 per cent this morning following a trading update from the group. Trading on all fronts has been strong for the group and it expects to report results in line with expectations, with revenue and order book increases of 28 and 39 per cent respectively. Buy." Canaccord have 1.63p now historic EPS for last year and Panmure have 1.5p EPS. For this year Canaccord have 1.82p EPS, and Panmure 1.8p EPS, rising to 2p EPS next year. Peel Hunt are the outliers, with historic 1.24p EPS and 1.48p EPS this year. I haven't got their research and tend to dismiss this as out of date - INSE made 0.78p EPS in H1 alone. Given 1.8p EPS for this year (2018) a 21.5p share price would seem extremely good value on a P/E of only 11.9.